最近召开的精神分裂症研究国际研讨会上报道的1期临床研究的初步结果提示，ampa－plex（Corte和Organon公司）联用氯氮乎治疗精神分裂症耐受性良好，并可改善病人的认知功能。这一安慰剂对照研究共有19例精神分裂症病人参加，其中一些病人接受本品联用氯氮平治疗4周。4周后联合 Preliminary results from phase 1 clinical studies reported at the recent International Symposium on Schizophrenia Research suggest that ampa-plex (Corte and Organon) in combination with clozapine is well tolerated for schizophrenia and improves the patient’s Cognitive function. In this placebo-controlled study, 19 schizophrenic patients were enrolled. Some of these patients were treated with clozapine for 4 weeks. 4 weeks after the union